Galcanezumab (LY 2951742) 是一种针对CGRP配体的人源化 IgG4 单克隆抗体。Galcanezumab 可用于偏头痛或丛集性头痛的研究。
| 生物活性 | Galcanezumab (LY 2951742) is a humanizedIgG4monoclonal antibody against theCGRP ligand. Galcanezumab can be used for migraine or cluster headaches research[1]. |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 中文名称 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
